TOP TIERMARKET NEWSWIRE

News & sentiment

ABIVAX SA ADR (ABVX) — News & AI sentiment

ABIVAX SA ADR (ABVX) news roundup. 4 stories in the past week, 4 over 30 days. Average 30-day sentiment is 55.5/100. No insider transactions filed in the last 90 days. US House Periodic Transaction Reports (90-day window): 1 purchase (~$33K) and 0 sales (~$0). Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →

24h stories

0

7d stories

4

avg sentiment 55.5/100

30d stories

4

avg sentiment 55.5/100

Insider net (90d)

$0

0 buys · 0 sells

Congress (90d)

1

1 buys · 0 sells

ABVX news in the last 24 hours, 7 days, 30 days and 90 days

How much ABVX coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time window	ABVX stories	Avg AI sentiment	Read
Last 24 hours	0	—	no coverage
Last 7 days	4	55.5/100	ABVX headlines →
Last 30 days	4	55.5/100	ABVX headlines →
Last 90 days	45	51.4/100	ABVX headlines →

Latest stories on ABVX

Goldman Sachs initiates Abivax stock coverage with buy rating

Investing.com Analyst Ratings61 · neutralanalyst

3d ago

Why is Abivax stock climbing today?

Investing.com Markets50 · neutralgeneral

3d ago

Abivax initiated with a Buy at Goldman Sachs

The Fly61 · neutralanalyst

4d ago

Ulcerative Colitis Market Outlook: 5 Late-Stage Drug Candidates to Watch | DelveInsight

GlobeNewswire50 · neutralgeneral

6d ago

Abivax Updates Share Capital and Voting Rights as of July 31, 2026

TipRanks50 · neutralgeneral

Aug 12

Abivax Gains FDA Alignment on NDA Path for Obefazimod—Paving Way for 2026 Filing in Ulcerative Colitis

MarketChameleon73 · bullishproduct/pr

Jul 31

Why is Abivax stock climbing today?

Investing.com Markets50 · neutralgeneral

Jul 31

Abivax Announces Positive Pre-NDA Interaction with the FDA for Obefazimod

StockTitan67 · bullishproduct/pr

Jul 30

Inflammatory Bowel Disease Market to Experience Strong Uptake During the Forecast Period (2026-2036), Driven by Development of Next-generation Therapies Targeting IL-23, TL1A, and S1P Pathways | DelveInsight

PR Newswire63 · neutralgeneral

Jul 30

Abivax Strengthens Commercial Capabilities With Strategic Leadership Appointments

StockTitan56 · neutralgeneral

Jul 23

Abivax: Obefazimod Goes The Distance And So Does My Buy Rating

Seeking Alpha73 · bullishanalyst

Jul 16

U.S. Chess Champion Backs Out Of Abivax and Casey’s, But Keeps Outpacing the S&P 500

TipRanks58 · neutralgeneral

Jul 13

Abivax CEO says $920M raise lets it launch its bowel disease drug in the U.S. solo

Quartz63 · neutralgeneral

Jul 10

Best defense is the offense, says Abivax CEO after takeover speculation

CNBC58 · neutralgeneral

Jul 10

Abivax: Wall Street Catches Up to the Data

MarketBeat67 · bullishproduct/pr

Jul 7

Abivax Announces Closing of $920 Million Public Offering | ABVX Stock News

StockTitan24 · bearishgeneral

Jul 6

Is ABIVAX Société Anonyme (ABVX) A Good Stock To Buy Now?

Yahoo Finance57 · neutralanalyst

Jul 3

Abivax stock surges as new trial data ease cancer fears over bowel disease drug

Quartz67 · bullishproduct/pr

Jul 3

Abivax stock plunges after cancer cases cloud bowel disease drug trial

Quartz28 · bearishearnings

Jul 3

Health Care Roundup: Market Talk

Yahoo Finance50 · neutralgeneral

Jul 2

Abivax raises $920M as underwriters fully exercise overallotment option

Seeking Alpha24 · bearishgeneral

Jul 2

ABVX Stock Eyes Over Six-Month High As Investors Double Down On Abivax's Lead Drug Bet – Buyout Chatter Builds

Stocktwits News58 · neutralgeneral

Jul 2

Abivax Shares Continue Climbing After Biotech Firm Moves to Bolster Balance Sheet

WSJ Markets24 · bearishgeneral

Jul 2

Abivax Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $920M (€807M) | ABVX Stock News

StockTitan24 · bearishgeneral

Jul 2

Abivax Prices $800M Offering Of ADS – Here’s A Look At Some Key Figures

Stocktwits News24 · bearishgeneral

Jul 1

Open ABVX in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →